Pacer Advisors
ANIP icon

Pacer Advisors’s ANI Pharmaceuticals ANIP Stock Holding History

Pacer Advisors’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.57M Buy
85,467
+5,548
+7% +$433K 0.02% 548
2025
Q4 		$6.31M Buy
79,919
+75,759
+1,821% +$6.56M 0.02% 616
2025
Q3 		$381K Buy
+4,160
New +$339K ﹤0.01% 1764
2025
Q1 		– Sell
-1,827
Closed -$101K – 3638
2024
Q4 		$101K Sell
1,827
-566,516
-100% -$32.5M ﹤0.01% 2641
2024
Q3 		$33.9M Buy
568,343
+565,910
+23,260% +$34.5M 0.07% 261
2024
Q2 		$155K Buy
2,433
+1,522
+167% +$98.8K ﹤0.01% 2000
2024
Q1 		$63K Buy
911
+165
+22% +$9.96K ﹤0.01% 3096
2023
Q4 		$41.1K Buy
+746
New +$41.1K ﹤0.01% 3167

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pacer Advisors's ANIP Position: Q1 2026 in Review

Pacer Advisors increased its ANI Pharmaceuticals (ANIP) stake by 6.9% in Q1 2026, buying an estimated $433K and bringing the position to 85,467 shares worth $6.57M. The position accounts for 0.02% of the portfolio, ranked #548.

Pacer Advisors first reported a position in ANIP in Q4 2023 and has held it in 8 quarters since. The position peaked at $33.9M in Q3 2024. 280 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.

  • Pacer Advisors held 85,467 shares of ANI Pharmaceuticals worth $6.57M as of Q1 2026.
  • Pacer Advisors bought 5,548 ANI Pharmaceuticals shares in Q1 2026, an estimated $433K.
  • ANI Pharmaceuticals made up 0.02% of Pacer Advisors's portfolio in Q1 2026, its #548 holding.
  • Pacer Advisors first reported a position in ANI Pharmaceuticals in Q4 2023 and has held it in 8 quarters since.
  • Pacer Advisors's ANI Pharmaceuticals position peaked at $33.9M in Q3 2024.
  • 280 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.

Based on Pacer Advisors's 13F filing for Q1 2026, filed 6 May 2026.